Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Immunotherapy Resistance in Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.

Cancer letters·2026
Same author

Epigenetic-Genetic Crosstalk at the Cancer-Diabetes Interface: Convergent Molecular Pathways, Multi-Omics Biomarkers, and Dual Therapeutic Targets.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Protein Kinase C-Delta (PKCδ) inhibition stabilizes endothelium and suppresses triple-negative breast cancer (TNBC) intravasation in a microfluidic hypoxic tumor model.

Bioengineering & translational medicine·2026
Same author

Design, synthesis, and in-vitro evaluation of 2-(heteroarylthio)acetamido-1<i>H</i>-benzo[<i>d</i>]imidazole derivatives as PTP1B inhibitors for the treatment of type 2 diabetes.

3 Biotech·2026
Same author

HDAC Inhibitors in Hematological and Solid Tumor Therapy: Current Success, Challenges, and Future Directions.

Current topics in medicinal chemistry·2026

Related Experiment Video

Updated: May 29, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Vacuolization as a Novel Approach to Cancer Therapy.

Mariah Pasternak1, Noor Hussein1, Veronica Piedra2,3

  • 1Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, Ohio, USA.

Journal of Biochemical and Molecular Toxicology
|May 28, 2026
PubMed
Summary

Compounds inducing vacuole formation can cause cancer cell death through nonapoptotic pathways like oncosis and paraptosis. Discovering new compounds is crucial for overcoming apoptosis-resistant cancers.

Keywords:
autophagydrug discoverymethuosisnonapoptotic cell deathoncosisparaptosis

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Experiment Videos

Last Updated: May 29, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Area of Science:

  • Cell Biology
  • Biochemistry
  • Cancer Research

Background:

  • Vacuoles perform vital cellular functions, including nutrient storage and waste degradation.
  • In cancer cells, vacuole formation can trigger non-apoptotic cell death mechanisms.
  • Non-apoptotic cell death pathways like oncosis, paraptosis, and methuosis offer alternative cancer treatment strategies.

Purpose of the Study:

  • To review compounds that induce vacuole formation and subsequent cell death, particularly in cancer cells.
  • To categorize and group these compounds based on their efficacy in inducing specific types of vacuole-mediated cell death.
  • To highlight the potential of targeting non-apoptotic cell death pathways for cancer therapy.

Main Methods:

  • Literature review of compounds inducing vacuole formation and cell death.
  • Categorization of compounds based on their mechanism of action and induced cell death pathway.
  • Analysis of the role of vacuoles in non-apoptotic cell death processes.

Main Results:

  • Several compounds induce vacuole formation, leading to cancer cell death via oncosis, paraptosis, or methuosis.
  • Vacuole-mediated cell death often involves distinct signaling pathways compared to apoptosis.
  • Compounds targeting these pathways present a promising avenue for treating apoptosis-resistant cancers.

Conclusions:

  • Compounds that induce vacuole formation represent a potential therapeutic strategy against cancer.
  • Targeting non-apoptotic cell death pathways is essential for overcoming treatment resistance.
  • Further research into categorizing and developing these compounds is warranted.